.png)
.png)
Total amount raised
$113M
Latest funding date
2025-09-29
Location
Kapiva has successfully raised funding through 9 rounds, with the most recent being a Series D round led by 360 ONE Asset and Vertex Growth Fund. The company is backed by 11 investors, including Vertex Ventures Southeast Asia & India and Vertex Growth Fund.
Kapiva specializes in modern Ayurvedic products aimed at providing complete nutrition, offering a variety of solutions for health concerns such as gym foods, heart care, and weight management. Keep reading to explore the intricacies of Kapiva's fundraising journey and the investors backing this innovative platform.
Kapiva, India's pioneer in modern Ayurvedic healthcare, has raised funding across multiple rounds backed by investors including 360 ONE Asset, Vertex Growth Fund, OrbiMed, 3one4 Capital, Vertex Ventures, and Fireside Ventures.
Keep reading to explore Kapiva's full fundraising journey, key investors, and what comes next for this modern Ayurveda brand.
What Is Kapiva?
Kapiva (operated by Adret Retail Pvt. Ltd.) is a D2C modern Ayurvedic healthcare brand founded in 2016 by Ameve Sharma and Shrey Badhani. Based in India, Kapiva merges traditional Ayurveda with modern science to deliver natural health solutions. The brand is distributed across approximately 40,000 stores spanning general trade, modern trade, pharmacy, and digital commerce channels, and is actively pursuing international expansion into the UK, US, and UAE.
How Much Funding Has Kapiva Raised?
- Seed / Early Stage (2017–2019)
- Amount Raised: Approximately USD 1.5M (Seed, ~2017); USD 2.52M (Series A, January 2019)
- Date: 2017 (Seed); January 2019 (Series A)
- Lead Investors: Fireside Ventures (Series A)
- Other Investors: Ventureast, angel investors
- Series B (October 2021)
- Amount Raised: Approximately USD 11M (INR ~80–85 crore)
- Date: October 2021
- Lead Investors: Vertex Ventures Southeast Asia & India
- Other Investors: Fireside Ventures, 3one4 Capital
- Series C (November 2022)
- Amount Raised: Approximately USD 28M (INR ~223 crore)
- Date: November 2022
- Lead Investors: OrbiMed
- Other Investors: Vertex Ventures, 3one4 Capital
- Series C Extension (September 2024)
- Amount Raised: USD 10M (INR ~83.5 crore)
- Date: September 23, 2024
- Lead Investors: OrbiMed Asia
- Other Investors: Vertex Ventures Southeast Asia & India, 3one4 Capital
- Series D – Primary Capital (September 2025)
- Amount Raised: USD 28M
- Date: September 29, 2025
- Lead Investors: 360 ONE Asset, Vertex Growth Fund (co-led)
- Other Investors: Vertex Ventures Southeast Asia & India, 3one4 Capital
- Secondary Market Transaction (September 2025)
- Amount: USD 32M
- Date: September 29, 2025
- Details: Secondary component of the Series D round, providing an exit to early investor Fireside Ventures. Led by 360 ONE Asset and Vertex Growth Fund.
Total Amount Raised: At least $113M based on disclosed funding (Seed ~$1.5M + Series A ~$2.52M + Series B ~$11M + Series C ~$28M + Series C Extension ~$10M + Series D Primary $28M + Secondary $32M).
Key Investors
- 360 ONE Asset
- Details: India-based asset management firm. Co-led Kapiva's Series D round (2025) alongside Vertex Growth Fund, investing in both primary and secondary components.
- Vertex Growth Fund
- Details: Singapore-based growth-stage venture fund. Co-led the Series D round (2025) and participated in both primary and secondary transactions.
- OrbiMed
- Details: New York-based healthcare-focused investor. Led Kapiva's Series C round (2022) and the Series C extension (2024), providing significant capital for Kapiva's expansion and product development.
- 3one4 Capital
- Details: Bengaluru-based venture capital firm. Has been a partner since 2020, participating across the Series B, Series C, Series C extension, and Series D rounds.
- Vertex Ventures Southeast Asia & India
- Details: Singapore-based venture firm. Led the Series B round (2021) and participated in Series C, Series C extension, and Series D rounds as a long-term institutional backer.
- Fireside Ventures
- Details: India-based consumer-focused VC. Was an early-stage lead investor (Series A, 2019) and exited via the secondary component of the Series D round in September 2025.
What's Next for Kapiva?
With $60 million raised in its Series D, Kapiva is focused on accelerating its international expansion into the UK, US, and UAE markets. Fresh capital will be deployed toward strengthening R&D and manufacturing capabilities, scaling brand presence, and building a health-tech ecosystem featuring digital consultations and personalized wellness journeys. Having achieved approximately 80% year-on-year growth over the past three years and an annual revenue run rate surpassing INR 550 crore, Kapiva is positioning itself as a global leader in evidence-based Ayurvedic wellness.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data. Sign up for free today.
